• Delivering Innovative Research
    to the Therapy Analysis market
    Find out more
  • Identifying and commercializing
    first-in-class innovation in early stage development
    Find out more
  • Thought provoking insights
    covering hot topics and key industry issues
    Find out more
  • Providing specialty research and data
    to the devices and diagnostics industries
    Find out more

Meaningful, innovative and evidence-based analysis to help inform key decision making

Our goal is to be the business intelligence partner of choice for companies in the healthcare arena looking for meaningful, innovative and evidence-based analysis to inform their key decision making.

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.

Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.

Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific.

The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

Find out more about GBI Research

Analyst Views

22 Jun 16
Combating Antimicrobial Resistance: Can Pharma Step Up to t....
In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses antimicrobial d.....
Read post
03 Jun 16
Diabetic Retinopathies: A market moving forward through pre....
In this Analyst View, Firas Nour, Associate Analyst for GBI Research, discusses rising le.....
Read post

White Papers

27 Oct 15
The Obesity Landscape: Obstacles to Current and Future Weig....
This white paper begins by examining the impact of the global obesity epidemic by conside....
Read post
16 Sep 15
Versatile Oncology Products: One Target for Many Sites....
This white paper begins with an assessment of the current status of the oncology market a....
Read post

Press Releases

21 Jun 16
Leukemia Has Largest Pipeline and Most First-in-Class Innov....
Of the three major indications within hematological cancer, namely leukemia, lymphoma and.....
Read post
14 Jun 16
Pharmaceutical Companies Increasingly Looking to Innovate H....
With the cost of bringing a single novel drug to market estimated to be $2.6 billion in 2.....
Read post